358 related articles for article (PubMed ID: 20477808)
1. Apoptosis of Hodgkin-Reed-Sternberg cells in classical Hodgkin lymphoma revisited.
Benharroch D; Einav I; Feldman A; Levy A; Ariad S; Gopas J
APMIS; 2010 May; 118(5):339-45. PubMed ID: 20477808
[TBL] [Abstract][Full Text] [Related]
2. Hodgkin lymphoma involving Waldeyer ring: a clinicopathologic study of 22 cases.
Quiñones-Avila Mdel P; Gonzalez-Longoria AA; Admirand JH; Medeiros LJ
Am J Clin Pathol; 2005 May; 123(5):651-6. PubMed ID: 15981804
[TBL] [Abstract][Full Text] [Related]
3. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
[TBL] [Abstract][Full Text] [Related]
4. Expression of the tumor necrosis factor receptor-associated factors (TRAFs) 1 and 2 is a characteristic feature of Hodgkin and Reed-Sternberg cells.
Izban KF; Ergin M; Martinez RL; Alkan S
Mod Pathol; 2000 Dec; 13(12):1324-31. PubMed ID: 11144929
[TBL] [Abstract][Full Text] [Related]
5. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
[TBL] [Abstract][Full Text] [Related]
6. Expression of Epstein-Barr virus latent membrane protein-1 in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma: associations with presenting features, serum interleukin 10 levels, and clinical outcome.
Herling M; Rassidakis GZ; Medeiros LJ; Vassilakopoulos TP; Kliche KO; Nadali G; Viviani S; Bonfante V; Giardini R; Chilosi M; Kittas C; Gianni AM; Bonadonna G; Pizzolo G; Pangalis GA; Cabanillas F; Sarris AH
Clin Cancer Res; 2003 Jun; 9(6):2114-20. PubMed ID: 12796376
[TBL] [Abstract][Full Text] [Related]
7. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
8. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
[TBL] [Abstract][Full Text] [Related]
9. Clonal relationship of classical hodgkin lymphoma and its recurrences.
Obermann EC; Mueller N; Rufle A; Menter T; Mueller-Garamvoelgyi E; Cathomas G; Dirnhofer S; Tzankov A
Clin Cancer Res; 2011 Aug; 17(16):5268-74. PubMed ID: 21737506
[TBL] [Abstract][Full Text] [Related]
10. Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.
Vockerodt M; Wei W; Nagy E; Prouzova Z; Schrader A; Kube D; Rowe M; Woodman CB; Murray PG
J Pathol; 2013 Aug; 230(4):399-409. PubMed ID: 23592216
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of cyclin a correlates with morphogenesis of reed-sternberg cells in Hodgkin lymphoma.
Chang KC; Chang Y; Jones D; Su IJ
Am J Clin Pathol; 2009 Jul; 132(1):50-9. PubMed ID: 19864233
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
[TBL] [Abstract][Full Text] [Related]
13. HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma.
Diepstra A; van Imhoff GW; Karim-Kos HE; van den Berg A; te Meerman GJ; Niens M; Nolte IM; Bastiaannet E; Schaapveld M; Vellenga E; Poppema S
J Clin Oncol; 2007 Jul; 25(21):3101-8. PubMed ID: 17536082
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin disease with subsequent transformation to CD30 positive non-hodgkin lymphoma in six patients.
Mori N; Watanabe K; Yamashita Y; Nakayama A; Yatabe Y; Narita M; Kobayashi T; Hasegawa Y; Kojima H; Nagasawa T
Cancer; 1999 Feb; 85(4):970-9. PubMed ID: 10091777
[TBL] [Abstract][Full Text] [Related]
15. The molecular pathogenesis of Hodgkin lymphoma.
Farrell K; Jarrett RF
Histopathology; 2011 Jan; 58(1):15-25. PubMed ID: 21261680
[TBL] [Abstract][Full Text] [Related]
16. [Mummified Hodgkin and Reed-Sternberg cells in EBV positive and EBV negative Hodgkin's lymphomas, Bcl-2 positivity and evaluation of survival].
Macák J; Bertová M
Vnitr Lek; 2001 Mar; 47(3):151-5. PubMed ID: 15635876
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus, cytokines, and inflammation: a cocktail for the pathogenesis of Hodgkin's lymphoma?
Khan G
Exp Hematol; 2006 Apr; 34(4):399-406. PubMed ID: 16569586
[TBL] [Abstract][Full Text] [Related]
18. Cell cycle and apoptosis deregulation in classical Hodgkin lymphomas.
Bai M; Papoudou-Bai A; Kitsoulis P; Horianopoulos N; Kamina S; Agnantis NJ; Kanavaros P
In Vivo; 2005; 19(2):439-53. PubMed ID: 15796209
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein expression by Hodgkin and Reed-Sternberg-like cells in acute infectious mononucleosis.
Isaacson PG; Schmid C; Pan L; Wotherspoon AC; Wright DH
J Pathol; 1992 Jul; 167(3):267-71. PubMed ID: 1381432
[TBL] [Abstract][Full Text] [Related]
20. HLA-G protein expression as a potential immune escape mechanism in classical Hodgkin's lymphoma.
Diepstra A; Poppema S; Boot M; Visser L; Nolte IM; Niens M; Te Meerman GJ; van den Berg A
Tissue Antigens; 2008 Mar; 71(3):219-26. PubMed ID: 18257895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
